Latest Asx News

Page 322 of 1422
Latrobe Magnesium successfully commissioned its Demonstration Plant producing magnesium oxide and secured $10 million in funding, while receiving a $200 million financing interest from the U.S. Export Import Bank for its next-stage commercial plant.
Maxwell Dee
Maxwell Dee
29 Oct 2025
Fitzroy River Corporation reported steady royalty income for the June quarter and highlighted significant progress on several royalty projects, including government approvals for Buru Energy’s Rafael Gas Project and a major equity raise for Endura Mining’s Snowy River Gold development.
Maxwell Dee
Maxwell Dee
29 Oct 2025
INOVIQ Limited has raised $9.5 million to advance its pioneering ovarian cancer screening test and CAR-exosome therapeutic programs, backed by strong preclinical data and strategic partnerships.
Ada Torres
Ada Torres
29 Oct 2025
Orthocell has appointed MontsMed as the exclusive distributor for its nerve repair product Remplir™ in Hong Kong, marking a significant step in its Asian commercialisation strategy. This move opens access to the vast Guangdong-Hong Kong-Macao Greater Bay Area, complementing existing operations in Singapore and planned expansion in Thailand.
Ada Torres
Ada Torres
29 Oct 2025
LTR Pharma has made significant strides towards its US market debut with ROXUS, bolstered by expert appointments and peer-reviewed clinical data validating its rapid-onset ED treatments.
Ada Torres
Ada Torres
29 Oct 2025
Carlton Investments reported a slight rise in net profit and an 8.7% increase in dividends for FY2025, while its investment portfolio grew nearly 60% over five years despite recent market fluctuations.
Claire Turing
Claire Turing
29 Oct 2025
Aruma Resources has reported promising high-grade copper intersections from its maiden drilling at Fiery Creek, alongside new heavy mineral sands and gold-copper targets, supported by a $3.515 million placement to fund ongoing exploration.
Maxwell Dee
Maxwell Dee
29 Oct 2025
Dimerix Limited reports solid progress in its Phase 3 trial for DMX-200 targeting rare kidney disease FSGS, backed by orphan drug status in Japan and a robust cash position. The company prepares to engage the FDA on new data supporting regulatory approval.
Ada Torres
Ada Torres
29 Oct 2025
Nagambie Resources has restarted diamond drilling at its Nagambie Mine, targeting new high-grade antimony-gold lodes east of its current resource, supported by a $1.2 million capital raise and strategic board appointment.
Maxwell Dee
Maxwell Dee
29 Oct 2025
Ansell Limited delivered a robust FY25 performance driven by organic growth, successful Kimberly-Clark PPE integration, and productivity gains, while advancing sustainability goals and managing trade headwinds.
Victor Sage
Victor Sage
29 Oct 2025
LGI Limited has launched a $5 million Share Purchase Plan offering eligible shareholders in Australia and New Zealand the chance to buy additional shares at a slight discount. The capital raise aims to fund the acceleration of key renewable energy projects.
Maxwell Dee
Maxwell Dee
29 Oct 2025
Sierra Nevada Gold (ASX, SNX) advances its Nevada gold projects with high-grade results and a new mining permit, while pursuing exploration licenses in Saudi Arabia and raising A$9.65 million in a strategic placement.
Maxwell Dee
Maxwell Dee
29 Oct 2025